These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20417709)

  • 1. Cancer cell specific targeting of nanogels from acetylated hyaluronic acid with low molecular weight.
    Park W; Kim KS; Bae BC; Kim YH; Na K
    Eur J Pharm Sci; 2010 Jul; 40(4):367-75. PubMed ID: 20417709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylated hyaluronic acid/photosensitizer conjugate for the preparation of nanogels with controllable phototoxicity: synthesis, characterization, autophotoquenching properties, and in vitro phototoxicity against HeLa cells.
    Li F; Bae BC; Na K
    Bioconjug Chem; 2010 Jul; 21(7):1312-20. PubMed ID: 20586473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of self-organizing nanogel with acetylated chondroitin sulfate as an anti-cancer drug carrier.
    Park W; Park SJ; Na K
    Colloids Surf B Biointerfaces; 2010 Sep; 79(2):501-8. PubMed ID: 20541919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate-mediated chondroitin sulfate-Pluronic 127 nanogels as a drug carrier.
    Huang SJ; Sun SL; Feng TH; Sung KH; Lui WL; Wang LF
    Eur J Pharm Sci; 2009 Aug; 38(1):64-73. PubMed ID: 19540339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels.
    Lee H; Mok H; Lee S; Oh YK; Park TG
    J Control Release; 2007 Jun; 119(2):245-52. PubMed ID: 17408798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
    Wiradharma N; Tong YW; Yang YY
    Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin.
    Yadav AK; Mishra P; Jain S; Mishra P; Mishra AK; Agrawal GP
    J Drug Target; 2008 Jul; 16(6):464-78. PubMed ID: 18604659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
    Eliaz RE; Szoka FC
    Cancer Res; 2001 Mar; 61(6):2592-601. PubMed ID: 11289136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes.
    Upadhyay KK; Bhatt AN; Mishra AK; Dwarakanath BS; Jain S; Schatz C; Le Meins JF; Farooque A; Chandraiah G; Jain AK; Misra A; Lecommandoux S
    Biomaterials; 2010 Apr; 31(10):2882-92. PubMed ID: 20053435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid nanogels with enzyme-sensitive cross-linking group for drug delivery.
    Yang C; Wang X; Yao X; Zhang Y; Wu W; Jiang X
    J Control Release; 2015 May; 205():206-17. PubMed ID: 25665867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid nanogels prepared via ortho ester linkages show pH-triggered behavior, enhanced penetration and antitumor efficacy in 3-D tumor spheroids.
    Yang G; Fu S; Yao W; Wang X; Zha Q; Tang R
    J Colloid Interface Sci; 2017 Oct; 504():25-38. PubMed ID: 28527297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery.
    Miao W; Shim G; Kang CM; Lee S; Choe YS; Choi HG; Oh YK
    Biomaterials; 2013 Dec; 34(37):9638-47. PubMed ID: 24016852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular delivery and anti-cancer effect of self-assembled heparin-Pluronic nanogels with RNase A.
    Choi JH; Jang JY; Joung YK; Kwon MH; Park KD
    J Control Release; 2010 Nov; 147(3):420-7. PubMed ID: 20688114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An insight on hyaluronic acid in drug targeting and drug delivery.
    Yadav AK; Mishra P; Agrawal GP
    J Drug Target; 2008 Feb; 16(2):91-107. PubMed ID: 18274931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ cross-linkable high molecular weight hyaluronan-bisphosphonate conjugate for localized delivery and cell-specific targeting: a hydrogel linked prodrug approach.
    Varghese OP; Sun W; Hilborn J; Ossipov DA
    J Am Chem Soc; 2009 Jul; 131(25):8781-3. PubMed ID: 19499915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery.
    Hang C; Zou Y; Zhong Y; Zhong Z; Meng F
    Colloids Surf B Biointerfaces; 2017 Oct; 158():547-555. PubMed ID: 28743090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-organized nanogels responding to tumor extracellular pH: pH-dependent drug release and in vitro cytotoxicity against MCF-7 cells.
    Na K; Lee ES; Bae YH
    Bioconjug Chem; 2007; 18(5):1568-74. PubMed ID: 17688320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid-coated single-walled carbon nanotubes loaded with doxorubicin for the treatment of breast cancer.
    Liu D; Zhang Q; Wang J; Fan L; Zhu W; Cai D
    Pharmazie; 2019 Feb; 74(2):83-90. PubMed ID: 30782256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells.
    Surace C; Arpicco S; Dufaÿ-Wojcicki A; Marsaud V; Bouclier C; Clay D; Cattel L; Renoir JM; Fattal E
    Mol Pharm; 2009; 6(4):1062-73. PubMed ID: 19413341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.
    Yu M; Jambhrunkar S; Thorn P; Chen J; Gu W; Yu C
    Nanoscale; 2013 Jan; 5(1):178-83. PubMed ID: 23076766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.